Value-Based Healthcare Model of Medical and Pharmaceutical Care for Patients With Coronary Artery Disease with Comorbid Conditions: Cost- Benefit Analysis in the Healthcare Setting of Ukraine

Abstract excerpt

<title>Abstract</title> <p> Pharmacotherapy of Coronary Artery Disease (CAD) with comorbid conditions is accompanied by severe polypharmacy and reduced patient adherence to treatment, which leads to a high incidence of cardiovascular Major Adverse Cardiovascular Events (MACE). Factors of the war in Ukraine (staff shortage, data fragmentation in eHealth of Ukraine) require the implementation of new Value-Based He...

Topics

Open a Topic to create a Post that cites this publication.

• Anticoagulants
• Atrial Fibrillation
• Cost-Benefit Analysis
• Croatia
• Drug Costs
• Health Care Costs
• Quality-Adjusted Life Years
• Warfarin

Identifiers and source

Literature Corpus work

3626c9a1-9a60-5c27-82cf-0fa07f11ef92

DOI

10.21203/rs.3.rs-9927500/v1